Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Completed · Phase 2 · Has a placebo group

Conditions studied: Pruritus

In brief

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Key facts

Study ID
NCT03841331
Run by
Vyne Therapeutics Inc.
People needed
233
Starts
2019-01-22
Expected to finish
2020-01-21
Last updated by the study team
2021-05-20

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.